CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies
Abstract:
The present invention provides novel bispecific antibodies that bind to human CD30 and uses thereof. Methods of treating cancer using the bispecific antibodies described herein are also provided.
Information query
Patent Agency Ranking
0/0